"PUNKT ZDROWIA to ośrodek wielospecjalistyczny zajmujący się prowadzeniem badań klinicznych oraz świadczeniem poradnictwa specjalistycznego w zakresie: chorób zakaźnych w tym boreliozy, zakażeń kobiet w ciąży, chorób przenoszonych drogą płciową, neurologii, hepatologii, alergologii, medycyny pracy oraz poradnictwa profilaktycznego chorób zakaźnych."

During the past decade, PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p." are "Hepatitis B, Chronic" (2 trials). Many other conditions were trialed in "PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p." in a lesser frequency.

Most popular intervention types in "PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cetrelimab" (1 trials), "ETV" (1 trials), "JNJ-73763989" (1 trials), "PegIFN-alpha-2a" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p." are 2 trials for "All" genders.

Currently, there are NaN active trials in "PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in PUNKT ZDROWIA Hlebowicz Jakubowski Lekarze sp.p., 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".